QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Press

10Oct 2024

Use Cases for Literature Reviews Across the Pharmaceutical Product development Lifecycle

Literature reviews are essential throughout the pharmaceutical product development lifecycle, from identifying therapeutic targets to assisting with regulatory and health technology assessment submissions and ultimately improving drug safety and patient outcomes at every stage.

This image presents the use cases for literature reviews across the life cycle of product development, something our Evidence Review and Synthesis team are experts in!

9Oct 2024

Driving innovation in Nordic SLD research🔍

Last week, Quantify’s Emilie Toresson Grip was invited to the first Swedish Steatotic Liver Disease (SLD) Think Tank, hosted by Karolinska Institutet.
24 hours packed with speed networking, group discussions, and insightful presentations.
The primary goals? Strengthening existing networks and fostering new connections across academia and industry.
The ultimate objective was to elevate Sweden and the Nordic countries’ position in international SLD research.

It’s an exhilarating time […]

7Oct 2024

Quantify is excited to attend the DIA RWE conference in Philadelphia!

Our CEO Kirk Geale, PhD will be attending the DRUG INFORMATION ASSOCIATION (DIA) Real-World Evidence conference in Philadelphia from October 24-25, 2024!

We are looking forward to meeting with clients and partners to showcase how our unique Nordic data can support global and US stakeholders with relevant and reliable RWE. Our highly transportable data has the power to answer research questions that […]

4Oct 2024

Health Economics Conference 2024 in Norway

Last week Quantify Research was present at the annual Health Economics Conference (Helseøkonomikonferansen) in Norway.

The conference gathered a broad audience and participation from academia, the healthcare sector, industry, patient organisations and government.
Over two days, the program was packed with presentations and discussions about hospital waiting times, the GP service, uncertainty and documentation in economic evaluation, perspectives and prioritisation in decision making, large public […]